Neurol. pro Praxi, 2002; 5: 260-263

Terapie demencí

MUDr. Irena Rektorová Ph.D
Centrum pro abnormální pohyby a parkinsonismus, I. neurologická klinika LF MU, FN u sv. Anny, Brno

Keywords: demence, Alzehimerova nemoc, inhibitory acetylchlinesterázy.

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rektorová I. Terapie demencí. Neurol. praxi. 2002;3(5):260-263.

V současné době není dostupná kauzální léčba a proto hlavním cílem je oddálit deterioraci kognitivních funkcí a snížit rychlost jejího postupu, léčit poruchy chování, deprese, anxietu, poruchy spánku, halucinace, paranoidní syndromy, řešit somatické potíže, které demenci provázejí (inkontinenci, poruchy polykání, bolesti aj.), komorbidity a interkurentní onemocnění. Komplexní léčba zahrnuje i psychosocioterapii (behaviorální trénink), rehabilitaci a práci s rodinou. Hlavním praktickým úkolem je umožnit setrvání pacienta v domácí péči v kruhu rodiny a zachovat či zlepšit schopnost sebeobsluhy a kvalitu provádění běžných denních aktivit, ale též snížení (nebo nezvyšování) zátěže a stresu pečovatelů. Důležitou a zatím jedinou obecně přijímanou prevencí demence je udržování stálé duševní aktivity, která může zvýšit rezervy mozku (tzv. -brain jogging-).

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM-IV, 4th edn. Washington, DC: American Psychiatric Association, 1993.
    2. Brun A, Englund B, Gustafson L, et al. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurgery Psychiatry 1994; 57: 416-418. Go to original source... Go to PubMed...
    3. Doody RS, Stevens JC, et al. Practice parameter: Management of dementia (an evidence-based review). Report of the Quality standards subcommittee of the American academy of neurology. Neurology 2001; 56: 1144-1155. Go to original source... Go to PubMed...
    4. Folstein MF, Folstein SE, McHugh PR., ,Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975; 12: 189-198. Go to original source... Go to PubMed...
    5. Frisoni GB. Treatment of Alzheimer's disease with acetylcholinesterase inhibitors: bridging the gap between evidence and practice. J Neurol 2001; 248: 551-557. Go to original source... Go to PubMed...
    6. Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992; 42: 473-480. Go to original source... Go to PubMed...
    7. Jellinger KA. What is new in degenerative dementia disorders? Wien Klin Wochenschr 1999; 111/17: 682-704.
    8. Jirák R. Kognitiva. Remedia 2001; 11: 419-422. Go to original source...
    9. Luxenberg JS. Clinical Issues in the Behavioural and Psychological Symptoms of Dementia. Int J Geriat Psychiatry 2000; 15: S5-S8. Go to original source...
    10. McKeith IG, Del Ser T, Spano P, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356: 2031-2036. Go to original source... Go to PubMed...
    11. McKeith IG, Galasko D, Kosaka P, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124. Go to original source... Go to PubMed...
    12. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944. Go to original source... Go to PubMed...
    13. Rektorová I. Demence. Kapitola ve Speciální neurologii. Skriptum LF MU, druhé rozšířené vydání, Brno, 1999.
    14. Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-260. Go to original source... Go to PubMed...
    15. Švestka J. Galantamin - dualistické kognitivum. Psychiatrie 2001; 4: 265-274.
    16. Waldemar G, Dubois B, Emre M, et al. Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. Eur J Neurol 2000; 7: 133-144. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.